Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10273-1 | Purvalanol A | LSM-3118 | 456214 | ||
10259-1 | ICRF-193 | LSM-4280 | 115150 | ||
10270-1 | Oxamflatin | LSM-4290 | 4611 | ||
10257-1 | GSK923295 | LSM-4278 | 68651179 | ||
10271-2 | PD 98059 | LSM-3394 | 4713 | ||
10262-1 | L-779450 | LSM-4283 | 9950176 | ||
10266-1 | NSC 663284 | LSM-2042 | 379077 | ||
10253-1 | Glycyl-H-1152 | LSM-4274 | |||
10251-1 | Fascaplysin | LSM-4272 | 73293 | ||
10240-1 | AS-252424 | LSM-4263 | 56965900 | ||
10268-1 | Nutlin 3a | LSM-6351 | 11433190 | ||
10267-1 | NU6102 | LSM-4287 | 4566 | ||
10255-1 | GSK1838705A | LSM-4276 | 25182616 | ||
10242-1 | Carboplatin | LSM-44959 | 5237030 | ||
10096-2 | ZM-447439 | LSM-1096 | 9914412 | ||
10026-3 | PD173074 | LSM-1026 | 1401 | ||
10107 | MG-132 | LSM-1107 | 462382 | ||
10228-2 | IKK16 | LSM-2309 | 9549298 | ||
10136-2 | TPCA-1 | LSM-1136 | 9903786 | ||
10107-2 | MG-132 | LSM-1107 | 462382 | ||
10107-5 | MG-132 | LSM-1107 | 462382 | ||
10108-2 | Geldanamycin | LSM-42789 | 644250 | ||
10250-1 | Etoposide | LSM-6348 | 36462 | ||
10275-1 | (Z)-4-Hydroxytamoxifen | LSM-43294 | 53770298 | ||
10274-1 | SB-3CT | LSM-4293 | 9883002 |